1. <rp id="4ug6k"><object id="4ug6k"><blockquote id="4ug6k"></blockquote></object></rp>
          <dd id="4ug6k"></dd>

            <em id="4ug6k"><object id="4ug6k"><input id="4ug6k"></input></object></em>
              Profile Core value Main business Legitimacy Social Responsibility
                Patents Research Direction Technology Strength
              API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
              Production management QC Quality System branch factory




              Products Center
            Paclitaxel (Semi-synthetic)
            Paclitaxel (Natural)
            Docetaxel Anhydrous
            Docetaxel Trihydrate
            Irinotecan HCl Trihydrate 99.5%
            Etoposide USP31
            Palonosetron Hydrochloride
              N-1 stage of Paclitaxel and Docetaxel
              Main Intermediates
            10-Deacetylbaccatin III
            Baccatin III
              Side chain for Paclixel semi-Synthetic
            (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
              Side chain of Docetaxel
            (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
              Side chain for Paclitaxel and Docetaxel
            Ethyl (2R,3S)-3-Phenylisoserine Ester
            Your location:Home>>About us>>Social Responsibility

            Jinhe is fully aware that the development of enterprises is not only trying to obtain more economic benefits, but also trying to make more contribution to society, being an "enterprise citizen” beneficial to society.
            Jinhe has always been conscientious of its production impact on environment, by actively controlling the emission of pollutants and heavily investing in the treatment of the pollutions. For many years, Jinhe has passed all inspection and assessment by State Environment Inspection Service.

            Jinhe focuses on the conservation of resources. Based on our own research results, Jinhe made in-depth study on the comprehensive utilization of Taxus, turning waste into useful, and greatly improved the comprehensive utilization efficiency of endangered species “Taxus”.

            Jinhe pays high attention on production cost control of anti-cancer drugs raw materials, and is committed to provide customers with low-cost raw materials of anticancer drug, thereby reducing the cost of anti-cancer drug products, so that more cancer patients can afford the expensive anticancer drug products, bringing more benefit to cancer patients.

            CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
            HOME About us Products R & D Production and QA Contact us CHINESE